Dr. K. Kiran Kumar

Medical Degrees

• MBBS — Dr. NTR University of Health Sciences, Andhra Pradesh, India, 2001
• MD (Radiotherapy) — Nizam's Institute of Medical Sciences (NIMS), Hyderabad, India, 2006
• DNB (Radiation Therapy) — National Board of Examinations, India

Fellowships & Special Training

• Recent Advances in Radiation Oncology — Certificate Programme, JFK Medical Center, New Jersey, USA, November 2008
• Fellowship in Palliative Medicine — Christian Medical Association of India, August 2007
• Faculty for Varian Clinical School (since 2018) — Yashoda Hospital, Hyderabad
• Specialised training in IMRT, IGRT, SRS, SRT, SBRT, TBI, TSET, and Brachytherapy

Certifications & Accreditations

• Telangana State Medical Council Registration
• Member — Association of Radiation Oncologists of India (AROI)
• Member — Indian Medical Association (IMA)
• DNB Faculty, Yashoda Cancer Institute, Hyderabad

Current Affiliation

• Yashoda Cancer Institute, Somajiguda, Hyderabad, India — Senior Consultant Radiation Oncologist (December 2008 – Present)
• Yashoda Hospitals, Hi-Tech City, Hyderabad, India — Consultant Radiation Oncologist (Present)
• Pi Health Cancer Hospital, Gachibowli, Hyderabad, India — Consultant Radiation Oncologist (Present)
• Kakatiya Hospital, Gachibowli, Hyderabad, India — Visiting Consultant (Present)

Past Affiliations

• Indo American Cancer Hospital and Research Center, Hyderabad, India — Registrar, Department of Radiation Oncology (Jan 2007 – Sept 2008)
• Christian Cancer Center, Kakinada, India — Consultant Radiation Oncologist (Past)
• Kamineni Hospitals, Hyderabad, India — Consultant Radiation Oncologist (Past)
• Mahatma Gandhi Cancer Hospital and Research Center, Vishakhapatnam, India — Consultant Radiation Oncologist (Past)
• Omega Hospitals, Hyderabad, India — Consultant Radiation Oncologist (Past)

Academic & Research Roles

• Faculty for DNB Radiation Oncology — Yashoda Cancer Institute, Hyderabad
• Faculty — Varian Clinical School (since 2018) for training consultants & physicists
• Principal Investigator on multiple international Phase III oncology trials
• CME speaker — including virtual CME on breast cancer for Bangladesh oncology community

Key Achievements

• 18+ years of clinical experience in radiation oncology
• Principal Investigator — LUX Head & Neck 2 Phase III trial (Trial No. 1200.131)
• Principal Investigator — Phase III trial on Afatinib vs Methotrexate in recurrent / metastatic head & neck cancer (Trial No. 1200.161)
• Principal Investigator — P276-00/64/11 multicentre Phase II/III trial on radiation-induced mucositis
• Customised treatment planning approach combining patient needs with evidence-based protocols